US Rx Drug Sales to Skyrocket During 2006

DECEMBER 01, 2005
Ken Rankin

The new Medicare Part D prescription drug program is expected to trigger a sharp increase in the demand for Rx medicines during the coming year, researchers at IMS Health predict. US sales of prescription drugs are projected to grow by between 8% and 9% in 2006—an increase almost 50% greater than the worldwide rise in demand for medicines and double the sales growth expected for many European countries.

Currently, US sales of prescription drugs total $230 billion, or 43% of the worldwide market for these products. The upsurge in demand next year figures to push the US share of the global pharmaceutical market even higher, according to IMS Health.

Mr. Rankin is a freelance medical writer.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.